Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma

Objectives and study design: In this population-based study of 602 patients, we amended C-reactive protein (CRP) and plasma albumin (PA) levels around the diagnosis of diffuse large B-cell lymphoma (DLBCL) to the International Prognostic Index (IPI) and assessed 0–90, 91–365, and +365-day survival....

Descripción completa

Detalles Bibliográficos
Autores principales: Gradel, Kim Oren, Larsen, Thomas Stauffer, Frederiksen, Henrik, Vinholt, Pernille Just, Iachina, Maria, Póvoa, Pedro, Zampieri, Fernando Godinho, Nielsen, Stig Lønberg, Dessau, Ram Benny, Møller, Jens Kjølseth, Jensen, Thøger Gorm, Chen, Ming, Coia, John Eugenio, Jelicic, Jelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896183/
https://www.ncbi.nlm.nih.gov/pubmed/35238275
http://dx.doi.org/10.1080/07853890.2022.2046287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896183/
https://www.ncbi.nlm.nih.gov/pubmed/35238275
http://dx.doi.org/10.1080/07853890.2022.2046287

Ejemplares similares